Anti-Human RPL22 Polyclonal Antibody

Anti-Human RPL22 Polyclonal Antibody: A Powerful Tool for Protein Synthesis Studies

The Anti-Human RPL22 Polyclonal Antibody is a highly specific and sensitive tool for studying protein synthesis in human cells. This antibody targets the ribosomal protein L22 (RPL22), a key component of the large ribosomal subunit, and is essential for the translation of genetic information into functional proteins.

Biological Function:
RPL22 is a highly conserved ribosomal protein that plays a crucial role in the formation of the ribosome, the cellular machinery responsible for protein synthesis. It is involved in the binding and positioning of the transfer RNA (tRNA) during translation, ensuring the accurate and efficient synthesis of proteins. Dysregulation of RPL22 has been linked to various diseases, making it a valuable target for research.

Main Applications:
The Anti-Human RPL22 Polyclonal Antibody is widely used in the field of biotechnology and molecular biology for various applications, including:

1. Protein Synthesis Studies: This antibody is an essential tool for studying the role of RPL22 in protein synthesis. It can be used for immunoprecipitation and western blotting to detect and quantify RPL22 levels in different cell types and conditions.

2. Disease Research: As mentioned earlier, RPL22 has been implicated in various diseases, including cancer and neurodegenerative disorders. The Anti-Human RPL22 Polyclonal Antibody can aid in understanding the role of RPL22 in disease development and progression.

3. Drug Development: The antibody can also be used to evaluate the efficacy of potential therapeutic drugs targeting RPL22. It can help researchers assess the impact of these drugs on RPL22 levels and protein synthesis.

Experimental Use Cases:
The Anti-Human RPL22 Polyclonal Antibody has been successfully used in several studies, including:

1. Identification of Novel Protein-Protein Interactions: By using this antibody for immunoprecipitation, researchers were able to identify new protein-protein interactions involving RPL22, shedding light on its role in protein synthesis.

2. Analysis of RPL22 Expression in Cancer: In a recent study, the antibody was used to analyze RPL22 expression in different types of cancer. The results showed a significant correlation between RPL22 levels and cancer progression, highlighting its potential as a diagnostic and prognostic marker.

3. Evaluation of RPL22 Inhibitors: The antibody was used to evaluate the effect of RPL22 inhibitors on protein synthesis in a study investigating potential treatments for neurodegenerative diseases.

In conclusion, the Anti-Human RPL22 Polyclonal Antibody is a valuable tool for studying protein synthesis and its role in various diseases. Its high specificity, sensitivity, and versatility make it an essential addition to any researcher’s toolkit. Order now to advance your research and gain a deeper understanding of RPL22 and its functions.